Space Peptides

Swiss-Chinese contract manufacturer offering peptide research, development and manufacturing services. Positions as premium quality provider with fast turnaround. Semaglutide API US DMF filed June 2026 (first overseas DMF clearance).

Directory assessment: Space Peptides is listed as a CDMO in the peptide supply chain, serving Europe markets from Switzerland / China. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is based on publicly available information and cross-referenced against industry databases. This supplier has a medium confidence score — verification signals are present, but the listing is newer or less documented; perform standard due diligence before engaging.